Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection
Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
† Study has passed its completion date and status has not been verified in more than two years.